Live Breaking News & Updates on Workflow estimates
Stay updated with breaking news from Workflow estimates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Active Pharmaceutical Ingredient CDMO Market Size, Share & Trends Analysis Report By Product, By Synthesis, By Drug, By Application, By...
/PRNewswire/ -- The "Global Automated and Closed Cell Therapy Processing Systems Market 2023-2030" report has been added to ResearchAndMarkets.com's offering....
/PRNewswire/ -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report by Drug Type (Small, Large Molecules), by Therapeutic Area...
Dublin, June 28, 2022 (GLOBE NEWSWIRE) -- The "Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report by Drug Type (Small, Large...
Share this article Share this article ResearchAndMarkets.com's offering. The global drug discovery outsourcing market size is expected to reach USD 5.4 billion by 2028 registering a CAGR of 7.4% over the forecast period. Drug discovery is a costly and lengthy process. This has forced pharmaceutical and biotech companies to opt for outsourcing their research activities to academic and private Contract Research Organizations (CROs). Thus, factors such as high R&D costs, patent expiration of best-selling drugs, and the need to speed up the drug discovery process, are expected to boost the demand for outsourcing of drug discovery in the coming years. Rising cases of chronic diseases have compelled companies to develop better medicines. Some of the key therapeutic areas where companies are actively involved in outsourcing include oncology, cardiovascular, and anti-infectives. In November 2020, AstraZeneca collaborated with 9 of the foremost oncology medical centers to expedite research in some of the hardest-to-treat cancers.